A DNA MELTOMETER AND METHODS OF USE THEREOF

Abstract: The invention provides an apparatus, termed a DNA meltometer, for the efficient, accurate, and reliable automated performance of DNA sizing, quantitating, probing and sequencing techniques, and methods for using the apparatus in clinical and diagnostic applications for the rapid diagnosis of pathological and disease states.

Description: A DNA MELTOMETER AND METHODS OF USE THEREOF BACKGROUND OF THE INVENTION 1. Field Of The Invention The invention relates to the fields of medical diagnostics and medical genetics, particularly with respect to molecular biological methods relevant to those fields. In particular, the invention provides methods and an apparatus for sizing, quantitating, probing and sequencing DNA fragments relevant to disease-related genetic polymorphisms and pathological organisms, cells and tissues. Specifically, the invention provides an apparatus, termed a DNA meltometer, for efficient, accurate, and reliable automated performance of DNA sizing, quantitating, probing and sequencing, and methods for using the apparatus in clinical and diagnostic applications for the rapid diagnosis of pathological and disease states. 2. Summary Of The Related Art In the fields of medical genetics and diagnostics, a variety of disease states are characterized by the presence of specific nucleic acids. In inherited diseases, for example, certain specific mutant genes are present in the genomic DNA of an individual. The reduced or absence of expression of the gene product of such specific mutant genes, or the expression of a mutant, non-fimctional gene product, or a gene product with altered or impaired function, causes or contributes to overt pathology or disease in the individual (see Scriver et al., 1989, The Metabolic Basis of Inherited Disease. McGraw-Hill, N.Y.). In infectious diseases, the presence of nucleic acid from the disease-causing organism is indicative of the presence of a disease or the imminent or eventual occurrence of the disease even in d e absence of immediate symptoms. One important example is infection with human immunodeficiency virus, which infection frequently antedates the appearance of the symptoms of acquired immunodeficiency syndrome by many years (see Fauci, 1988, Science 239: 617-622). A second category of diseases that are not genetic in origin are the so-called environmentally-induced diseases. Such diseases are caused by toxic, antigenic or nutritional effects of environmental toxins and other insults on cells and tissues. The resulting molecular pathologies may be identified through the detection of alterations in patterns of gene expression in affected cells and tissues. Thus, specific detection of such indicative nucleic acids has potential as an important diagnostic tool for the clinician. Over the last decade, research in human genetics has undergone enormous advances, and in over one hundred human diseases a genetic lesion has been identified associated with the disease (Antonarakis, 1989, N. Engl. J. Med. 320: 153- 163). The techniques used in the discovery and characterization of these disease- associated DΝA polymorphisms include: (I) in vitro amplification of specific nucleic acid sequences, particularly using the polymerase chain reaction; (2) separation and sizing of nucleic acid fragments using gel electrophoresis; (3) detection of particular nucleic acid fragments amongst a multiplicity of such fragments by specific hybridization of nucleic acid bound to various membranes (so-called "Southern" and "Northern" hybridizations); and (4) determination of nucleotide sequences by degradative or, more frequently, synthetic sequencing methods (see Sambrook et al., 1990, Molecular Cloning: A Laboratory Manual. 2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. for a detailed description of these techniques). As robust as these techniques have been in the research laboratory, transfer of these technologies to the clinical lab has proven to be difficult. In particular, automation and standardization of these techniques to routine clinical and diagnostic applications has been slow. This is due in part to the fact that all of these techniques typically have involved agarose or polyacrylamide gel electrophoresis as a final characterization step. Gel electrophoresis, while effective in the research setting, is cumbersome, difficult to automate and requires skilled laboratory personnel to perform. In addition, gel electrophoresis techniques typically involve the use of hazardous chemicals, such as ethidium bromide (which is mutagenic) and acrylamide (a neurotoxin), radioactivity, and/or hazardous conditions, such as high voltages (up to 4000V) or the use of ultraviolet transiUuminators. In addition, visualization of specific DNA fragments separated in gels usually requires photographic equipment, a darkroom, and X-ray film-developing equipment, all of which makes these techniques less economical to use and increases the level of skill required to reliably perform these analyses. There is thus a need in the clinical diagnostic arts for a simple, robust and easily-automated alternative to gel electrophoresis which could be used by technicians having considerably less skill in the molecular biological arts than is required to perform the currently available gel electrophoretic methods. Even within the molecular biological arts, certain areas of ongoing, important research, including the Human Genome Project (see Olson et al. , 1989, Science 245 : 1434-1435) are limited in the rate at which advances can be achieved by the amount of time consumed using currently-available, electrophoresis-based nucleic acid size separating methods. Advantageous features of an alternative to these methods include rapid "run" times, ease of use, high throughput, and automated operation by conventionally-trained clinical laboratory technical personnel. BRIEF SUMMARY OF THE INVENTION The present invention provides a "gel-free" nucleic acid detection and characterization system, comprising an apparatus and mefliods for using the apparatus to size, quantitate, probe and sequence nucleic acid without the use of gel electrophoresis. The invention provides nucleic acid detection in a single, easy-to- use, automatable instrument, termed a DNA meltometer. The meltometer is comprised of the following components, in operative combination: a thermomodulating chamber in which the temperature can be accurately, reliably and rapidly adjusted to any temperature between about 15 °C and 95-100°C; temperature controllers including heating elements and cooling or refrigeration units in thermal contact with the thermomodulating chamber for adjusting the temperature in the thermomodulating chamber; and a detector for detecting d ermal denaturation of double-stranded DNA or RN A: DNA hybrids , i. e. , for detecting single-stranded DNA or RNA produced as the result of thermal denaturation of double-stranded DNA or RNA:DNA hybrids. Optionally and advantageously, the meltometer is also comprised of a data-processing device and an interface whereby the data-processor controls the operation of the other components of the apparatus and collects, records and stores data produced by operation of the apparatus. Also optionally included in the components of the meltometer is a pump for moving a liquid buffer solution through the thermomodulating chamber, preferably arranged to cause a flow of buffer through the thermomodulating chamber and past the detector; in such embodiments of the apparatus of the invention, the thermomodulating chamber advantageously has a first opening and a second opening, whereby buffer flows into the chamber through the first opening and out from the chamber through the second opening, which second opening is connected with or attached to the detector. The apparatus and methods provided by the invention are useful for: (a) sizing nucleic acids ranging in length from about 50 to about 500 basepairs (bps) in length; (b) quantitating an amount of a specific DNA fragment, either alone or in a mixture of heterologous DNA fragments; (c) detecting a specific nucleotide sequence of a nucleic acid among a plurality of non-specific nucleotide sequences by hybridization to a sequence-specific nucleic acid probe; and (d) detecting a nested set of extended nucleic acid sequencing oligonucleotides ranging in length from about 20 to about 100 nucleotides, each extended oligonucleotide having at its 3' extent a polymerase chain-terminating compound, thereby providing for gel-free nucleotide sequencing of nucleic acids. The present invention is based on the following technical considerations. Nucleic acids have conventionally been characterized by gel electrophoresis on the basis of their physical size, the most important parameter of which is length. Apart from physical size, another property characteristic of any double-stranded nucleic acid is the temperature at which the two complimentary strands dissociate from one anotiier. This property, termed the melting temperature, T m , is defined as the temperature at which 50% of the nucleic acid molecules have dissociated into their component single strands. The T m of a given small (less than approximately 600 basepairs) nucleic acid is known to depend on two factors: the size (i.e. , length) of the fragment, and the sequence and base composition of the fragment. Size contributes to T m because the longer a nucleic acid is, the more hydrogen-bonded basepairs it contains, which thereby require more thermal energy to be broken apart. Base composition effects are due to d e fact that G ≡ C basepairs are more stable than A=T basepairs because they share more inter-strand hydrogen bonds between d e basepairs. Base sequence effects are due to d e fact that the bases interact with one another within each strand in a manner that stabilizes the double-stranded conformation. The use of various formulae to predict the T m of a DNA duplex of known length an base composition is well known in the art. The instant invention for the first time provides an apparatus and methods for using die T m of a DNA fragment to identify its length and (in some embodiments of the methods of the invention) its base composition. The effects of base composition and sequence on T m can be removed by me use of isostabilizing compounds. These compounds bind specifically to GC or AT basepairs, and act to destabilize or stabilize, respectively, the hydrogen bonding between the basepairs. In the presence of isostabilizers, the T m of some nucleic acid fragments becomes a function solely of its length. In addition, isostabilizers sharpen the melting transition, thereby increasing the resolution of detection of different nucleic acid fragments which differ in length, for example, by even a single nucleotide. Specific preferred embodiments of die present invention will become evident from me following more detailed description of certain preferred embodiments and d e claims. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 illustrates the structure and operation of the thermomodulating chamber of the DNA meltometer, wherein 1 represents the direction of flow of temperature-controlled buffer, 2 represents tethered DNA, consisting of 3 an immobilized strand and 4 a detectably-labeled strand, 5 represents die thermomodulating chamber, 6 represents the detector, 7 represents a tethered DNA retainer and 8 represents a thermally-denatured, detectably-labeled, single-stranded DNA or RNA molecule. Figure 2 illustrates an automated embodiment of me DNA meltometer, wherein 5 represents the thermomodulating chamber, 6 represents the detector, 9 represents a pump for moving buffer through the thermomodulating chamber 5, 10 represents a buffer reservoir, 11 represents a data-processor for controlling operation of the apparatus and 12 represents an interface enabling the computer to control operation of the apparatus and to collect and store data produced by the apparatus. Figures 3A and 3B show Tm determinations in die presence Figure 3B) and absence (Figure 3A) of the isostabilizer tetraethylammonium chloride for a 497 basepair (bp) DNA fragment using die meltometer. Figure 4 demonstrates Tm and size determination of nested and non-nested fragments in the presence and absence of d e isostabilizer tetraethylammonium chloride using the meltometer, Figures 5A through 5D illustrate detection of multiplex probes hybridized to a DNA template and sequentially denatured and detected using the meltometer. Figures 5A d rough 5C illustrate Tm-based detection of tixree (Figures 5A and 5B) or four (Figure 5C) probes, and Figure 5D shows a conventional gel electrophoretic analysis of the DNA fragments separated as shown in Figure 5C, where lane 1 are DNA size markers of a 15mer, a 23mer (mismatch) and a 30mer; lane 2 are DNA size markers of a 15mer, a 23mer and a 30mer; lanes 3-6 are recovered meltometer peaks containing a 15mer (lane 3), a mismatch 23mer (lane 4), a 23mer (lane 5) and a 30mer (lane 6). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention provides an apparatus, termed a DNA meltometer, for gel-free sizing, quantitating, probing and sequencing nucleic acid fragments, preferably double-stranded DNA fragments. The DNA meltometer is based on die principle that the T m of a DNA fragment under die appropriate conditions is essentially a function of the length of the DNA fragment. Methods for sizing, quantitating, probing and sequencing DNA fragments, in the absence or in the presence of isostabilizing compounds, are also provided by the invention. The apparatus is comprised of an ti ermomodulating chamber (5 in Figure 1) for containing a buffer solution of a double-stranded nucleic acid such as DNA wherein the DNA is d ermally denatured d erein. Exemplary embodiments of such an thermomodulating chamber include a thin-walled polypropylene tube contained widiin a heating block comprised of a heat-conducting material, which embodiment advantageously is limited to a single use to avoid die possibility of cross- contamination of samples. Another embodiment of the thermomodulating chamber component of me meltometer is a cell or chamber comprised of heat-conducting material and defining a cavity having at least one opening for inserting a sample and flushing such a sample after each sample determination. Advantageously, d e thermomodulating chamber of the meltometer has a first and second opening, allowing the flow of a liquid buffer solution, a liquid sample-containing solution or any other liquid solution through the chamber. In such embodiments of e meltometer are included a pump (9 in Figure 2) for moving buffer from a buffer reservoir (10 in Figure 2) through the diermomodulating chamber and past a detector (6 in Figures 1 & 2). An example of a pump useful in this embodiment of the DNA meltometer is a high pressure liquid chromatography pump (available from Beckman Scientific Instruments, Fullerton, CA). In additional embodiments, ie thermomodulating chamber is defined by a number of sample wells allowing multiple determinations to be made sequentially or contemporaneously. In certain embodiments, the thermomodulating chamber is also comprised of a double-stranded nucleic acid retainer (7 in Figure 1). Exemplary retainers include but are not limited to Teflon ® filters for retaining nucleic acid fragments mat have been tethered to latex beads. Another example of an advantageously-used retainer is an external magnetic field generator for retaining nucleic acid fragments that have been tethered to ferrous metal-binding agents, such as transferrin or paramagnetic beads (available from Dynal, Oslo, Norway). The thermomodulating chamber of the meltometer is in thermal contact with temperature controlling devices such as heating elements and/or cooling or refrigerating units for regulating the temperature within d e chamber. A variety of such temperature regulating units are known to those with skill in this art, including but not limited to metallic heating strips, cooling fans, refrigeration units, and die like. In particular, temperature regulators are known which are capable of regulating temperature to within ±1°C, more preferably ±0.1 °C, and most preferably ±0.01 °C (an example of which is a temperature controller available from Eppendorf, Hamburg, Germany). Thermal-denaturation of nucleic acid, comprising the dissociation of a double- stranded nucleic acid into single-stranded DNA or RNA, is detected using a detector (6 in Figures 1 & 2) that detects a physical property unique to the single-stranded conformer of a DNA fragment. Such properties may be detected by essentially three categories of detectors: direct detectors, semi-direct detectors and indirect detectors. Direct detection of diermal denaturation can be achieved, for example, using a calorimeter to detect the heat of dissociation released when a double-stranded nucleic acid denatures into its component single strands. Another example of direct detection is spectrophotometric detection. In diis detection method, what is detected is d e increase in absorbance of ultraviolet light at a wavelength of 260nm that is associated widi thermal denaturation (d e so-called denaturation hyperchromicity effect). Such direct methods will be understood by diose with skill in the art to be limited by me requirement of nanomoles ( ~ 10 14 molecules) of target nucleic acid. Semi-direct metiiods of thermal denaturation detection include detection of die binding or dissociation of single- or double-strand conformation specific dyes and intercalating compounds. Thus, for example, thermal denaturation may be detected by d e increase in the effective concentration of a spectrophotometrically-detectable double-strand specific dye, binding moiety or intercalating compound. Typically, diese types of dyes absorb or emit light at a certain wavelength in a way that depends on whedier or not the dye is bound to, associated wid or intercalated into a double- stranded DNA molecule. Using tiiese types of dyes, die amount of the dye diat is bound to, associated wid or intercalated into a double-stranded DNA molecule can be detected by the increase (or decrease) in absorbance or emission of light at die appropriate wavelength as the DNA molecule is thermally denatured. Alternatively, thermal denaturation may be detected by die decrease in the effective concentration of a spectrophotometrically-detectable single-strand specific dye, binding moiety or intercalating compound. These dyes are similar to double-strand specific dyes in ti at the amount of light absorbed or emitted at a particular and characteristic wavelength depends on whedier or not the dye is bound to, associated widi or intercalated into a single-stranded DNA molecule. Thus, using these types of dyes, die amount of the dye diat is bound to, associated wid or intercalated into a single-stranded DNA molecule can be detected by the increase (or decrease) in absorbance or emission of light at the appropriate wavelength as the amount of single-stranded DNA increases with thermal denaturation of the double-stranded DNA. More complex "sandwich"- type systems are known, wherein additional specific binding components are involved in intermediate steps between thermal denaturation and d e increase or decrease in the effective concentration of a detectable dye, binding moiety or intercalator. In such systems, the binding or release of either a dye or an intermediate specific binding moiety is detected spectrophotometrically by the increase or decrease in the effective concentration of the detectable dye. A variety of useful nucleic acid- specific dye compounds are known, including, for example, ethidium bromide, or preferably, DAPI, Hoechst 33258, and, most preferably, TOTO/YOYO (Molecular Probes, Eugene, OR). The use of this latter dye enables detection of as little as femtomoles ( ~ 10 9 molecules) of target nucleic acid (see Glazer & Hays, 1992, Nature 359: 859). Indirect detection methods include, but are not limited to, fluorescence or infrared spectrophotometry of fluorescently- or infrared-tagged single-stranded DNA or RNA. Fluorescence detection is preferably used in embodiments of me meltometer comprising flow of a liquid buffer solution through the d ermomodulating chamber and past the detector, under conditions and using an thermomodulating chamber wherein undenatured nucleic acid is retained witiiin the diermomodulating chamber. An example of such an arrangement is shown in Figure 1. In this example of indirect detection using d e apparatus of the invention, a liquid buffer solution, preferably an aqueous buffer solution such as standard citrate saline (SSC; see Sambrook et al. , 1990, ibid.) is made to flow (wherein 1 represents the direction of flow of temperature-controlled buffer) through the thermomodulating chamber 5 at a temperature that is initially below the T m of me particular DNA fragment of interest. In the chamber is a sample of tethered DNA 2 retained therein by a retainer 7. The tethered double-stranded DNA consists of an immobilized strand 3 and a detectably-labeled, preferably a fluorescently- or infrared-labeled strand 4. As d e temperature in the thermomodulating chamber is increased, the DNA denatures at a characteristic temperature (the T and d e detectably-labeled strand is moved by the flow of buffer from the thermomodulating chamber 5 past a detector 6, where it is detected as a tiiermally-denatured, fluorescently- or infrared-labeled, single- stranded DNA or RNA molecule 7. The use of fluorescence-based or infrared-based indirect detection memods can enable detection of 1000-2000 molecules in solution (Middendorf et al., 1992, Electrophoresis 13: 487), or even of a single molecule (Davis et al., 1991, GATA 8: 1), theoretically. In the use of the meltometer provided by the invention, nucleic acid to be sized, quantitated, probed or sequenced is advantageously modified to comprise a tethering molecule on one strand. Incorporation of such a tethering molecule provides a way to retain the double-stranded nucleic acid in the thermomodulating chamber and to prevent detection of undenatured DNA by d e detector. This is accomplished by tethering, anchoring or immobilizing the double-stranded nucleic acid inside the diermomodulating chamber. The undenatured DNA may be anchored, tethered or immobilized to die diermomodulating chamber itself, or more preferably to a retainer (7 in Figure 1) within the thermomodulating chamber. Advantageous combinations of temering molecules and retainers include but are not limited to biotinylated nucleic acids linked to streptavidin-coated latex or glass beads, and retained wid in the thermomodulating chamber by a Teflon ® membrane. Also included in such advantageous embodiments of die invention are nucleic acids linked to a magnetic metal, with or widiout the use of a chelating moiety such as porphyrin or ferritin, and retained within ie thermomodulating chamber by the application of an external magnetic field. Temering molecules can be added to d e double stranded nucleic acid by replacement synthesis, hybridization, chemical modification or during in vitro chemical synthesis or in vitro amplification. In the use of the meltometer provided by die invention, nucleic acid to be sized, quantitated, probed or sequenced is advantageously modified to comprise a detectable label on d e one strand. Incorporation of such a detectable label provides a way to detect denaturation of d e double-stranded nucleic acid. One non-limiting example of a preferred detectable label is a fluorescent label such as fluorescein or rhodamine, or an infrared label such as a polymethine dye. Detectable label molecules can be added to d e double stranded nucleic acid by replacement syntiiesis, hybridization, chemical modification or during in vitro chemical synthesis or in vitro amplification. Also included in diis aspect of the invention is the non-covalent incorporation of a detectable label into die double-stranded nucleic acid, for example, intercalation of single-strand or double-strand conformation-specific detectable dyes. Examples of such nucleic acid conformation-specific dye molecules include but are not limited to ethidium bromide, or preferably, DAPI, Hoechst 33258, and, most preferably, TOTO/YOYO. In addition and advantageously, the solution within the buffer chamber is comprised of a isostabilizing compound. Exemplary isostabilizing compounds include betaine, sarcosine, taurine, glycerol, TMAO, TMAC1, TEAC1, among odiers, the isostabilizing properties of which are disclosed in accompanying Table I. TABLE I Data Sources: 1 Wood et al (1985) Proc. Natl. Acad. Sci. USA 82: 1585-1588 2 Melchior, WB and von Hippi PH (1973) Proc. Natl. Acad. Sci. USA 70: 298-302 3 Rees, et al (1993) Biochemistry 32: 137-144 Yancey et al (1982) Science 217: 1214-1222 Use of such isostabilizing compounds is advantageous because diese compounds increase the degree to which the T m of a nucleic acid is proportional to its length (see Wood et al., 1985, Proc. Natl. Acad. Sci. USA 82: 1585-1588). In addition, isostabilizing compounds of e invention act to sharpen the melting transition, i.e. , they act to decrease d e range of temperature over which a double-stranded nucleic acid changes from being essentially completely double stranded to being essentially completely single stranded (see Rees et al., 1992, Biochemistry 32: 137). This feature is advantageous because it results in increased resolution of different nucleic acids diat differ by, at d e limit, a single basepair. such as the nested set of extended oligonucleotides which represent the products of a DNA replacement-synthesis sequencing reaction. The DNA meltometer is provided in a preferred embodiment as an automated apparatus. A schematic diagram of this embodiment of ie meltometer is shown in Figure 2. In this embodiment, the operational steps are controlled by an interface unit (12 in Figure 2), preferably an I/O interface such as, for example, an Omega OM-900 unit, controlled by a data-processor (11 in Figure 2), such as a computer. Operational steps include control of the temperature regulating units, control of the flow rate of buffer through the diermomodulating chamber, and control of the detection of diermal denaturation by die detector. Also a feature of this preferred embodiment of the meltometer is the use of d e computer to acquire, record and store data generated by operation of die apparatus. The DNA meltometer provided by the invention is useful to enable gel-free sizing, quantitating, probing and sequencing of nucleic acids. The mediod of sizing a nucleic acid fragment, for example, a DNA fragment, provided by the invention comprises the steps of placing a solution comprising the DNA fragment in the diermomodulating chamber of the meltometer at a temperature less than the tiiermal- denaturation temperature of the DNA fragment. The temperature of the diermomodulating chamber is then incrementally raised linearly and stringently (± 0.01 to 1°C) at a rate sufficient to detect and resolve denaturation of the DNA fragment. Thermal denaturation of the DNA fragment is thereby detected. In preferred embodiments, one strand of d e DNA fragment is linked to a tediering molecule and retained in the diermomodulating chamber via a retainer. The other strand of die fragment is linked to a detectable label diat is, for example, a fluorescent label or an infrared label. The thermomodulating chamber is advantageously arranged to have a first and second opening whereby buffer flows through the diermomodulating chamber during the course of thermal denaturation. The thermally-denatured single-stranded, fluorescently- or infrared-labeled DNA molecules flow past die detector as die result of buffer flow from through the diermomodulating chamber, and are diereby detected. In an advantageous modification of diis method, a set of DNA size marker fragments are added to d e diermomodulating chamber. Such marker fragments are preferably differentially labeled such diat d e detector can discriminate between each of the marker fragments and die sample DNA fragment. The size of the DNA sample fragment is then determined by comparison with a standard curve prepared using die tiiermal denaturation temperatures detected for each of the DNA marker fragments. The method of quantitating a DNA fragment comprises the additional step of calculating me amount of the DNA fragment detected by the detector. In one embodiment, the amount of die fragment detected is quantitated from die total intensity of the detected labeled DNA, using algorithms well-known in the art such as Beers' law to relate the absorbance at a particular wavelength to die amount of the absorbing substance. The method of probing a nucleic acid fragment, for example, a DNA fragment, to specifically detect a particular DNA fragment from among a multiplicity of DNA fragments provided by die invention comprises the following steps. One strand of each of die multiplicity of double-stranded DNA fragments is linked to a ted ering molecule. A solution of a multiplicity of tethered double-stranded DNA fragments is then placed in die diermomodulating chamber of the meltometer in the presence of a retainer, so that the multiplicity of double-stranded DNA fragments are retained in die diermomodulating chamber. The temperature of the diermomodulating chamber is then raised to a temperature sufficient to tiiermally denature die multiplicity of DNA fragments. Alternatively, thermal denaturation can be accomplished prior to addition of die DNA sample to die diermomodulating chamber. This thermal denaturation results in there being a multiplicity of single- stranded DNA fragments present in the thermomodulating chamber that are targets for later hybridization widi a sequence-specific probe. A detectably-labeled nucleic acid probe is dien hybridized to die multiplicity of DNA fragments in a hybridization solution, said probe being preferably an oligonucleotide that specifically hybridizes to die particular DNA fragment of interest among the multiplicity of DNA fragments, at a temperature sufficient to allow said hybridization to occur. Excess probe is then removed from die diermomodulating chamber and die temperature in the diermomodulating chamber then incrementally raised linearly and stringendy (± 0.01 to 1 °C) at a rate sufficient to detect and resolve denaturation of die hybridized oligonucleotide probe from the particular DNA fragment of interest. The thermally- denatured oligonucleotide probe is then detected by the detector. In preferred embodiments, one strand of the multiplicity of DNA fragments is linked to a temering molecule and retained in die thermomodulating chamber via a retainer. The oligonucleotide is linked to a detectable label diat is a fluorescent label or an infrared label. The diermomodulating chamber is arranged to have a first and second opening whereby buffer flows through the diermomodulating chamber during die course of thermal denaturation. The diermally-denatured oligonucleotide, fluorescently- or infrared-labeled probe then flows past the detector as the result of buffer flow through the diermomodulating chamber and is d ereby detected. The method of sequencing a nucleic acid fragment, for example, a DNA fragment, as provided by die invention comprises the following steps. One strand of each of a multiplicity of double-stranded DNA fragments is linked to a tethering molecule and a solution of d e multiplicity of tethered double-stranded DNA fragments is placed in die diermomodulating chamber of the meltometer in me presence of a retainer, so that the multiplicity of double-stranded DNA fragments are retained in ie diermomodulating chamber. The temperature of the diermomodulating chamber is then raised to a temperature sufficient to thermally denature the multiplicity of DNA fragments. Alternatively, thermal denaturation can be accomplished prior to addition of d e DNA sample to the diermomodulating chamber. This thermal denaturation results in there being a multiplicity of single- stranded DNA fragments present in the diermomodulating chamber that are targets for later hybridization widi a sequence-specific probe. An oligonucleotide sequencing primer that specifically hybridizes to die DNA fragment at a site in the nucleotide sequence of d e DNA fragment adjacent to d e site to be sequenced is tiien annealed to die denatured DNA. This annealing step is performed at a temperature sufficient to allow annealing of the primer to the template DNA to occur. Conventional dideoxynucleotide/ replacement synthesis nucleic acid sequencing reactions are then performed to create a nested set of extended oligonucleotides hybridized to die DNA fragment. The temperature in the diermomodulating chamber is then incrementally raised linearly and stringently (± 0.01 to 1°C) at a rate sufficient to detect and resolve denaturation of each of d e nested set of extended oligonucleotides hybridized to die DNA fragment of interest. Each species of the nested set of d e extended oligonucleotides is then detected by d e detector in a temporal sequence that reflects the nucleotide sequence of d e DNA fragment. In preferred embodiments, one strand of d e multiplicity of DNA fragments, i.e. , the strand complimentary to the oligonucleotide primer, is linked to a tethering molecule and retained in d e diermomodulating chamber via a retainer. Each of the nested set of extended oligonucleotides is detectably labeled at die 3' terminus by a fluorescently-labeled or an infrared-labeled dideoxy terminator residue. Optionally and advantageously, each of die dideoxynucleotides can be differentially labeled so as to be individually detectable by the detector. The diermomodulating chamber is arranged to have a first and second opening whereby buffer flows through the diermomodulating chamber during me course of thermal denaturation. Each of the diermally-denatured, fluorescently- or infrared-labeled extended oligonucleotides tiien flows past the detector as the result of buffer flow through the thermomodulating chamber and is diereby detected in a temporal sequence mat reflects the nucleotide sequence of die DNA fragment. It will also be understood by tiiose with skill in tiiis art that the meltometer may be used to assay virtually any biomolecular interaction than can be dissociated into component parts. The only requirement is that one of the interacting molecules be capable of being tethered witiiin the meltometer, and at least one of die otiier interacting molecules be capable of being detectably labeled, for example, by a fluorescent or radioactive label. In addition to die temperature ramping or gradient technique described for DNA analysis, solution ramping, for example, using gradients of salt concentration, dielectric constant, chaotropic agent concentration, or mono- or divalent cation concentration, may be used. One non-limiting example is protein-DNA interactions, wherein the interaction can be measured for DNA binding activity of the protein. In this example, DNA could be te iered to the meltometer chamber as described above, and fluorescently tagged protein be allowed to interact wid die tethered DNA. Proteins could tiien be specifically eluted wid a salt gradient and detected by a fluorescence spectrophotometer, providing a quantitative measure of the strength of the binding interaction between the DNA and protein. Other advantageous uses of die DNA meltometer described herein will be apparent to those of ordinary skill in tiiis art, and fall within die ambit of the disclosed invention. The following Examples are intended to further illustrate certain preferred embodiments of the invention and are not limiting in nature. EXAMPLE 1 Detecting, Sizing and Quantitating a Specific PCR Product using the DNA Meltometer Polymerase chain reactions are performed using standard techniques. A DNA sample comprising the DNA template to be amplified is mixed at a final concentration of about 10 4 molecules/reaction in a reaction mixture containing a first oligonucleotide PCR primer of between 15 and 30 nucleotides, d at is homologous to a DNA sequence flanking the DNA fragment to be amplified, and d at is labeled at the 5' end wid a tetiiering molecule such as biotin. Also in the reaction mixture is a second oligonucleotide PCR primer of between 15 and 30 nucleotides, that is homologous to a DNA sequence flanking the DNA fragment to be amplified, and on d e strand opposite to d e strand homologous to d e first PCR primer, said second PCR primer being labeled at die 5' end wid a fluorescent molecule such as rhodamine or fluorescein or an infrared label such as a polymethine dye. Each of the PCR primers is present in the reaction mixture at a final concentration of lμM. The reaction mixture also contains: (1) a DNA polymerase such as the thermostable polymerase from T. aquaticus (available from Perkin Elmer-Cetus, Emeryville, CA) at a final concentration of l-5U/reaction; (2) each of 4 deoxynucleotide triphosphates, at a total dNTP concentration of about 200μM; and (3) a buffer appropriate for the polymerase enzyme used, d e buffer typically containing a magnesium ion salt at a concentration of l-5mM. The DNA fragment is amplified following an amplification protocol involving repeated cycles of denaturation of double-stranded DNA, annealing and polymerase- catalyzed extension of the oligonucleotide primers. Amplification is performed for between 10-40 cycles, or until approximately 50-1500 ng (1-100 picomole) of the DNA fragment have been produced. The specific DNA fragment is detected using d e DNA meltometer as follows. To the PCR reaction comprising the amplified fragment is added a solution containing streptavidin-coated latex beads of a size sufficient to be retained by a Teflon ® filter. After binding of die amplified DNA fragments to the latex beads via the biotinylated end of one strand of each fragment, e mixture of latex bead-bound DNA fragments are placed into the thermomodulating chamber of the meltometer, the chamber containing a Teflon ® retaining filter. The thermomodulating chamber is equilibrated to a temperature that is less than the tiiermal denaturation temperature of e DNA fragment before use, and is typically equilibrated to a temperature of 15 °C. The pump is used to generate a flow of a buffer solution through the thermomodulating chamber and past a detector, which is calibrated to detect the fluorescently- or infrared-labeled strand of die DNA fragment. Each of the control steps herein described for performance of the DNA fragment detection is preferably performed by a computer in combination with a I/O interface, and d e data generated from the detector is also recorded by die computer to form a permanent record of d e experiment. To detect d e specific amplified DNA fragment, the temperature of the thermomodulating chamber is incrementally raised linearly and stringently (± 0.01 to 1°C) at a rate sufficient to detect and rs : ve denaturation of die DNA fragment. Optionally, also contained in the thermomodulating chamber is a set of DNA size marker fragments, wherein each fragment is labeled on one strand with biotin and attached thereby to a streptavidin-coated latex bead, and is labeled on the other strand with a fluorescent label or an infrared label. Also optionally contained in the thermomodulating chamber is an amount of an isostabilizing compound. The DNA fragment is detected by the detection of die appropriate signal by the detector. The accuracy of tiiis determination is increased by a comparison of the observed size of the DNA fragment, relative to the DNA size marker fragments, with the expected size of the DNA fragment. Additionally, die amount of the specific DNA detected can be determined by integration of the total absorbance of labeled DNA fragments detected, using well- known algorithms for such a purpose. The amount of a particular detected fragment will be related to the total absorbance detected at the appropriate wavelength that is specific for that fragment. The use of specific detectable labels is particularly advantageous for this purpose. EXAMPLE 2 Detecting Specific Hybridization of DNA with an Oligonucleotide Probe using the DNA Meltometer Hybridization of a genetic polymorphism-specific probe with human genomic DNA is achieved as follows. DNA from an individual diagnosed as a carrier of the sickle cell anemia trait [GTG (Glu 6 ) → GAG (Val 6 ) in the human /3-globin gene] is digested wid a restriction enzyme that does not destroy the polymorphism and diat produces a recessed 3' end of each restriction fragment. The DNA is then labeled widi ferritin under standard conditions (see Sambrook et al., ibid.), for example, by performing a fill-in reaction of the 3' recessed end using d e Klenow fragment of E. coli DNA polymerase I or T4 DNA polymerase and ferritinylated dUTP. The ferritinylated DNA sample is first denatured and then placed into the thermomodulating chamber of the meltometer, the chamber being supplied widi an external magnetic field generator. Said magnetic field is applied tiiroughout the remaining course of the experiment. An oligonucleotide hybridization probe diat is homologous to the sickle cell anemia-associated allele of human 3-globin and labeled, for example, at the 5' end, widi a fluorescent molecule such as rhodamine or fluorescein or an infrared label such as a polymethine dye, is added to d e diermomodulating chamber. The temperature of the thermomodulating chamber is then adjusted to a temperature below the thermal denaturation temperature of the oligonucleotide probe with its homologous site in the human genomic DNA of the DNA sample. Hybridization is performed for an appropriate amount of time to allow the maximum amount of specific hybridization to occur, and tiien excess unhybridized probe is washed from the thermomodulating chamber using a wash solution [typically comprised of 0.1-1 % sodium dodecyl sulfate (SDS) in 0.1-2X standard saline citrate (SSC), IX SSC being comprised of 0.15M NaCl and 0.015M sodium citrate, pH 7.0)]. The pump is used to generate a flow of the washing solution through the thermomodulating chamber and past a detector, which is calibrated to detect d e labeled probe. Each of the control steps herein described for performance of the DNA fragment detection is preferably performed by a computer in combination with a I/O interface, and the data generated from the detector is also recorded by d e computer to form a permanent record of the experiment. When the detector no longer detects the passage of any excess unhybridized probe, die temperature of the thermomodulating chamber is incrementally raised linearly and stringently (± 0.01 to 1°C) at a rate sufficient to detect and resolve denaturation of the oligonucleotide probe from the genomic DNA and to allow detection of the denatured DNA probe. The oligonucleotide is detected by die detection of the appropriate signal by the detector. If DNA from an individual heterozygous for the sickle cell anemia trait is used, two distinct thermal denaturation events, occurring at 2 different temperatures, are expected to be detected. The first is the denaturation of the probe from the site of the non-sickle cell anemia-associated allele, which denaturation will occur at the lower temperature because of the presence of a mismatch at the site of the mutation between the genomic DNA and d e oligonucleotide probe. The second denaturation event detected will be denaturation of the probe from the site of the sickle cell anemia-associated allele, which denaturation will occur at the higher temperature because of the exact match at the site of the mutation between the genomic DNA and die oligonucleotide probe. Optionally, also contained in the thermomodulating chamber is a set of DNA size marker fragments, wherein each fragment is labeled on one strand with ferritin and retained thereby in the thermomodulating chamber by the externally-applied magnetic field, and is labeled on the other strand widi a fluorescent or infrared label. Also optional contained in the thermomodulating chamber is an amount of an isostabilizing compound. The accuracy of this determination is increased by a comparison of the observed size of the DNA fragment, relative to the DNA size marker fragments, with the expected size of the DNA fragment. EXAMPLE 3 DNA Sequencing using the DNA Meltometer Dideoxynucleotide/ replacement synthesis nucleic acid sequencing of a site of a genetic polymorphism is performed, and a nested set of extended oligonucleotides detected using the DNA meltometer as follows. DNA from an individual diagnosed as a carrier of the genetic polymorphism that causes cystic fibrosis (deletion of the three-base codon encoding Phe 463 in the cystic fibrosis transmembrane regulator gene) is digested with a restriction enzyme that does not destroy the polymorphism and that produces a recessed 3' end of each restriction fragment. The DNA is then labeled with biotinylated dUTP by fill-in reaction of the 3' recessed end using the Klenow fragment of E. coli DNA polymerase I or T4 DNA polymerase, under standard conditions (see Sambrook et al., ibid, for details of this protocol). Alternatively, a DNA fragment encompassing the site of the genetic polymorphism is produced by in vitro amplification, for example, as described in Example 1. The biotinylated DNA sample is then denatured and mixed witii streptavidin- coated latex beads and then placed into die diermomodulating chamber of the meltometer, the chamber containing a Teflon ® retaining filter. A DNA sequencing oligonucleotide primer that hybridizes to a site flanking the polymorphism in the cystic fibrosis-associated DNA fragment is then added to the diermomodulating chamber. A mixture of a DNA polymerase, the appropriate buffers and unlabeled dNTPs, and each of four differentially fluorescently- or infrared-labeled dideoxynucleotide triphosphates is then added to die diermomodulating chamber, at a temperature that allows the sequencing primer to anneal and die polymerase to incorporate dNTPs and ddNTPs into a set of extended oligonucleotides encompassing the cystic fibrosis polymorphic site. After an appropriate amount of time to allow the maximum amount of oligonucleotide extension to occur, the excess sequencing reaction mixture is flushed from the thermomodulating chamber using the pump to generate a flow of washing solution as in Example 2 above through the thermomodulating chamber and past a detector, which is calibrated to detect each of die labeled ddNTPs. Each of the control steps herein described for performance of the DNA fragment detection is preferably performed by a computer in combination with a I/O interface, and d e data generated from the detector is also recorded by the computer to form a permanent record of the experiment. When the detector no longer detects d e passage of any excess free ddNTPs, die temperature of the thermomodulating chamber is incrementally raised linearly and stringently (± 0.01 to 1°C) at a rate sufficient to detect and resolve denaturation of each of the nested set of extended oligonucleotides hybridized to d e DNA fragment of interest and to allow detection of the differentially-labeled extended oligonucleotide primers. The extended oligonucleotides are detected by die detection of the appropriate signal by the detector. The DNA sequence is determined by the temporal sequence of die detected signal past the detector. Optionally contained in die diermomodulating chamber is an amount of an isostabilizing compound. A theoretical thermal denaturation profile for sequencing of the sequence CAGTCCGTAACATCTAGCCGAGGAAGACTCTGCCATGCCAAGGAGC (SEQ ID No. : l) using the oligonucleotide primer GATCTAGCTATTAG (SEQ ID No.:2) is shown in Table II. The data in this Table were derived as follows. By analyzing nearest-neighbor thermodynamic parameters (see Breslauer et al., 1986, Proc. Natl. Acad. Sci. USA 83: 3746), the increase in T m (in °C) of the sequence was determined as single nucleotides were added to d e oligonucleotide primer. As can be seen in the Table, in theory about 60 basepairs of DNA sequence can be read using the DNA meltometer over a thermal denaturation profile of 22.5 °C -* 82.6 °C, particularly in view of the fact that temperature regulators are commercially available having a precision of ±0.01 °C. TABLE II fragment size 15 20 25 30 35 40 45 50 EXAMPLE 4 DNA Sizing Analysis of Specific PCR Products using the DNA Meltometer DNA fragments produced by polymerase chain reaction were sized as described in Example 1. A nested set of seven DNA fragments of different lengtiis was produced using bacteriophage M13mpl8 as template (the sequence of which is known, see, for example, New England Biolabs Catalog, Appendix). The nested set was produced using a set of PCR primers in which a single, common sense-oriented (i.e., 5') primer was used in individual reactions with one of a set of unique 3' primers, located along die M13mpl8 sequence at increasing distance 3' from the 5' primer site. This resulted in a nested set of DNA fragments sharing a common 5' end and increasing amounts of M13mpl8 DNA sequence in size order 3' from this common end. The identity of the primers used is detailed in Table III, where each primer is identified as sense (F) or antisense (R) and by die position of die 5' end of each primer relative to the M13mpl8 sequence. In the performance of these PCR reactions, the 5' common primer was biotinylated, and die 3' primer was labeled with 32 P using γ- 32 P labeled ATP and T4 polynucleotide kinase; this reaction was performed according to the manufacturers instructions (New England Biolabs, Beverly, MA) and standard techniques (Sambrook et al., ibid.). PCR reactions using these primers (30pmol each primer) were performed using standard reaction conditions (see PCR Protocols. Academic Press: New York, 1990) for 30 cycles, where each cycle consisted of 0.5 min at 94°C, 0.5 min at 50°C and 0.5 min at 72°C. These PCR reactions yielded a nested set of PCR product DNA fragments of 67, 115, 154, 321, 497, 763 and 1000 bp . In addition, a non-nested 30 bp fragment and two unrelated PCR product DNA fragments of 138 bp and 508 bp were similarly generated from phage lambda DNA. The PCR products were extracted once each widi buffer-equilibrated phenol and chloroform, ethanol precipitated, and resuspended in water at a concentration of 0.3 pmole/μL. In preparation for DNA sizing using the meltometer, 50 μg of streptavidin- coated M-280 Dynabeads (Dynel, Oslo, Norway) were washed three times in binding buffer (IM NaCl, lOmM Tris-HCl, pH 7.5, ImM EDTA). 1.5 pmol of each PCR product DNA fragment generated s described above were bound to Dynabeads in 50 TABLE III 10 ι * * 15 20 product DNA fragment generated as described above were bound to Dynabeads in 50μL binding buffer by incubation with 50μg Dynabeads for 30 min at room temperature. The resulting suspension of DNA bound to Dynabeads was tiien washed three times in binding buffer and three times in meltometer buffer. Two formulations of meltometer buffer were used in this study: NaCl buffer (50mM NaCl, lOmM Tris-HCl, pH 7.5, ImM EDTA, 0.1 % (v:v) TWEEN 20) and TEAC1 buffer (2.4M TEAC1, 5mM KH 2 PO 4 , ImM EDTA). Each of the ten PCR product DNA fragments generated as described above were individually sized using die meltometer. Two determinations were made for each DNA fragment: one using the NaCl buffer, and the other using the TEAC1 buffer. The meltometer was maintained at 25 °C during loading of the bead-bound DNA. Buffer flow was maintained at 30 μL/min and diverted to waste during loading. The DNA-bound beads were diluted to 100μL in the appropriate meltometer running buffer and injected directly into the meltometer heating block, which was equipped witii a size exclusion frit of 0.5μm. After loading, buffer flow was re-directed tiirough the meltometer and the sample washed for at least 5 min at 25 °C prior to the start of the heating profile. Each DNA meltometer size determination was performed using a temperature profile wherein the temperature was raised from 25°C to 99.5°C at l°C/min. Fractions were collected at 0.5°C intervals directly onto strips of Whatman 3MM filter paper. The amount of radioactive DNA in each fraction was determined by Cherenkov counting using a scintillation counter (Beckman, Model LS6000IC, Mountainview, CA). The T m s determined using the meltometer for each of these DNA fragments are shown in Table III (T m (2)). In addition, for each PCR product generated, a tiieoretical T m was calculated, using the equation: T m = 81.5 + 16.6(log[Na + ]) + 0.41(% GC content) - 600/DNA fragment length (see Sambrook et al., ibid, at p. 9.51). These calculated results are shown in Table III (T m (l)). Comparison of these T m s indicates diat the calculated T m in each case is less than the T m found using the meltometer. Figures 3 A and 3B show a comparison of DNA meltometer T m determination for a particular DNA fragment (497bp) using NaCl buffer (Figure 3A) or TEAC1 buffer (Figure 3B). In each determination, high resolution T m peaks were observed, but the T m was lowered 26.2°C in the determination using TEACl buffer. This result illustrates that TEACl is compatible with the meltometer. A comparison of DNA fragment size versus T m is shown in Figure 4 for the DNA fragments described herein. The upper curve shown in the Figure represents the nested set of DNA fragments analyzed using NaCl buffer. The shape of this smooth curve indicates that there is a high correlation between T m and DNA fragment size in this set of nested fragments. This is as expected, since die fragments form a related set sharing significant identity at tiieir 5' extents. It can also be seen that the non-nested fragments do not fit on tiiis curve. The deviations of die non-nested DNA fragments suggests that differences in DNA sequence and base composition have influenced die observed T m s. The lower curve represents the nested set of DNA fragments analyzed using TEACl buffer. The T m s of the DNA fragments in this curve are uniformly lower than the T m s observed using NaCl buffer, consistent with the results shown in Figures 3 A and 3B. In addition, in this experiment the non-nested fragments now fall on die TEACl curve, demonstrating that use of this isostabilizer has eliminated DNA sequence and base composition effects, and made T m dependent solely on DNA size. This comparison of the predicted DNA fragment size of the non-nested DNA fragments shown in Figure 4 is further illustrated in Table IV below, where the predicted DNA fragment size using the meltometer under conditions of NaCl buffer and TEACl buffer are compared. This comparison shows that the use of isostabilizers can increase the accuracy of DNA fragment size prediction from 50- 73% observed using NaCl buffer, to 81-93% using TEACl buffer. These results demonstrate that the DNA meltometer can be used to accurately size DNA fragments over a range of at least 30-5O0bps, and that the use of the isostabilizer TEACl can eliminate the base composition and sequence-specific contributions to the T m using the meltometer. EXAMPLE 5 Detecting Specific Hybridization of DNA with Oligonucleotide Probes using the DNA Meltometer DNA hybridization witii specific oligonucleotide probes was performed as described in Example 2. Multiplex hybridization (i.e. , simultaneous hybridization with multiple probes) was performed with four different oligonucleotides on a 115bp PCR product DNA fragment. The 115bp PCR product was generated using M13mpl8 DNA as DNA template and 30pmoles each of 5' biotinylated primer M6192F (sense primer; SEQ ID No.: 3) and unmodified M6306R (antisense; SEQ ID No. : 4). PCR was performed essentially as described in Example 4. After PCR, the DNA fragment produced was extracted once each with buffer-saturated phenol and chloroform, ethanol precipitated and resuspended in water at a concentration of 0.3pmol/μL. 50μg streptavidin-coated M-280 Dynabeads were prepared by washing three times in binding buffer (IM NaCl, lOmM Tris-HCl, pH 7.5, ImM EDTA) and tiien the beads were bound to 1.5pmol PCR product DNA fragment in 50μL binding buffer by incubating at room temperature for 30 min. Thereafter, the bead-DNA conjugates were washed three times with binding buffer, and die non-biotinylated strand eluted by washing the beads three times with a solution of 0. IN NaOH/0.1 % (v:v) TWEEN 20 for 15 min. The beads were then again washed three times with binding buffer. Radiolabeled probes were prepared by T4 DNA kinase-catalyzed addition of 32 P at the 5' end of each primer. 16.6pmol γ- 32 P-labeled ATP were used in a reaction mixture containing 20pmol of each primer and appropriate amounts of buffer salts and T4 DNA kinase as recommended by the manufacturer (New England Biolabs). The oligonucleotides used as probes were: M6191C (15mer; SEQ ID No. : 15), M6306R (30mer; SEQ ID No.:5), M6258R (23mer; SEQ ID No. :4) and M6258MM (23mer, including a single basepair mismatch; SEQ ID No. : 16). Kinased oligonucleotides were purified from unincorporated nucleotides by NAP-5 column chromatography (obtained from Pharmacia, Uppsala, Sweden). The recovered kinased oligonucleotides were dried and resuspended in water at a concentration of 0.2pmol/μL. The nucleotide sequences of die primers and probes used in tiiis Example are shown in Table V. TABLE V (The mismatch site in probe M6306MM is designated by underlining) For hybridization studies, 50μg of bead-bound, single-stranded PCR product DNA was incubated with a mixture of Ipmol apiece of the kinased complementary oligonucleotide probes in 50μL binding buffer for 30 min at room temperature. The probe mixtures used were as follows: in the experiment depicted in Figure 5A, probes M6192C (15mer), M6306R (23mer) and M6258R (30mer) were used; in the experiment depicted in Figure 5B, probes M6192C (15mer), M6306MM (mismatch 23mer) and M6258R (30mer) were used; and in the experiment depicted in Figure 5C, probes M6192C (15mer), M6306R (23mer), M6306MM (mismatch 23mer) and M6258R (30mer) were used. After hybridization, the beads were washed three times in binding buffer and three times in meltometer buffer (50mM NaCl, lOmM Tris- HC1, pH 7.5, ImM EDTA, 0.1 % (v:v) TWEEN 20) at room temperature to remove non-specific hybridization. Each of the three mixtures were separately tested using the meltometer. The meltometer was maintained at 25 °C during loading of the bead-bound, hybridized DNA. Buffer flow was maintained at 30μL/min and eluate was directed to waste during loading. The beads were diluted to 100μL in meltometer buffer and injected directly into the heating block of the meltometer, which was equipped with a 0.5μm size exclusion frit. After loading, buffer flow was redirected to die meltometer and the sample washed at 25 °C for at least 5 min prior to each hybridization determination. Hybridized oligonucleotide probes were eluted from the DNA template using a temperature profile, characterized as increasing from 25 °C to 99.5°C at a rate of 1°C per minute. 0.5 °C fractions were collected directly onto strips of Whatman 3MM filter paper. The amount of radioactive DNA in each fraction was determined by Cherenkov counting using a scintillation counter (Beckman Model LS6000IC). The results of these experiments are shown in Figures 5 A through 5D. Figures 5A through 5C show that each of the different probes was efficiently detected using the meltometer, and each eluted from the DNA template at a characteristic temperature that was easily discriminated for each probe sequence. Of particular relevance is the discrimination that was found between the wild-type probe M6306R and the mismatch probe M6306MM. These results demonstrate discrimination between these primers differing at a single position in the 23- nucleotide sequence, both in comparing separate multiplex hybridizations (Figures 5A and 5B) and when both probes were contained in the same multiplex hybridization (Figure 5C). Figure 5D shows conventional acrylamide gel electrophoretic analysis of the fractions corresponding to die meltometer peaks shown in Figures 5 A through 5C. These results demonstrate that the DNA meltometer can efficiently discriminate and detect hybridization of 15mer through 30mer probes hybridized to a bead-bound DNA template and can discriminate on the level of a single base mismatch. It should be understood that the foregoing disclosure emphasizes certain specific embodiments of the invention and that all modifications or alternatives equivalent thereto are within the spirit and scope of the invention as set forth in the appended claims. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: Ganmera Bioscience (B) STREET: 30 Memorial Drive (C) CITY: Cambridge (D) STATE: Massachusetts (E) COUNTRY: USA (F) POSTAL CODE (ZIP) : 02142 (G) TELEPHONE: 617-441-1080 (H) TELEFAX: (617) -441-1010 (ii) TITLE OF INVENTION: A DNA Meltometer and Methods of Use Thereof (iii) NUMBER OF SEQUENCES: 16 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, Version #1.25 (EPO) (v) CURRENT APPLICATION DATA: APPLICATION NUMBER: PCT/US95/ (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 46 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: CAGTCCGTAA CATCTAGCCG AGGAAGACTC TGCCATGCCA AGGAGC 46 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 14 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: GATCTAGCTA TTAG 14 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C). STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3 : AACAATTTCA CACAGGAAAC 20 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: GAGGATCCCC GGGTACCGAG CTCGAATTCG 30 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: GTAAAACGAC GGCCAGTGCC AAG 23 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: TAAGTTGGGT AACGCCAG 18 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: CTCAGGAAGA TCGCACTC 18 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: GTCTGGCCTT CCTGTAGC 18 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: TTTGAGAGAT CTACAAAGGC 20 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: TCAGAGCATA AAGCTAAATC 20 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11: TTTTTATGTC GATGTAC 17 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12 : GAATTTGTGA GAGATAGAC 19 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: GATGAGTTCG TGTCCGTACA ACTGGCGT 28 (2) INFORMATION FOR SEQ ID NO:14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14: CGAACAGGTT ATCGAAATCA GCCAC 25 (2) INFORMATION FOR SEQ ID NO:15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15: TTCCTGTGTG AAATT 15 (2) INFORMATION FOR SEQ ID NO:16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16: GTAAAACGAC GCCCAGTGCC AAG 23

Claims: WE CLAIM: 1. An nucleic acid analysis apparatus comprising, in combination, a thermomodulating chamber, wherein a temperature is defined; heating and cooling means that are in thermal contact with the thermomodulating chamber, for controlling the temperature of the thermomodulating chamber; and a detecting means for detecting diermally-denatured double-stranded DNA at a temperature that is about the T m of each nucleic acid to be analyzed, diereby sizing, quantitating, probing or sequencing the nucleic acid. 2. A method for detecting a double-stranded DNA fragment from a multiplicity of double-stranded DNA fragments by detecting tiiermal denaturation of said double-stranded DNA fragment, the method comprising: (a) placing the multiplicity of double-stranded DNA fragments in the thermomodulating chamber of the apparatus of Claim 1 in a solution at a temperature less than the thermal-denaturation temperature of said DNA fragment; (b) incrementally raising the temperature in the thermomodulating chamber linearly and stringently to a temperature that is at least the thermal- denaturation temperature of said DNA fragment; and (c) detecting the thermally-denatured DNA fragment at a temperature that is the thermal denaturation temperature of the DNA fragment. 3. The apparatus of Claim 1 wherein the detecting means is a calorimeter. 4. The apparatus of Claim 1 wherein the detecting means is a fluorescence detector. 5. The apparatus of Claim 1 wherein the detecting means is an ultraviolet spectrophotometer. 6. The method of Claim 2 wherein one of the strands of the DNA fragment is detectably labeled. 7. The method of Claim 6, wherein the detectable label is a fluorescence label. 8. The method of Claim 2 wherein one of the strands of each of die DNA fragments is labeled with a tethering molecule. 9. The method of Claim 8 wherein the tethering molecule is biotin or ferritin. 10. The apparatus of Claim 1 wherein the thermomodulating chamber optionally comprises means for retaimng DNA fragments labeled with a tethering molecule. 11. The apparatus of Claim 10 wherein the double-stranded DNA retaining means is a Teflon ® filter. 12. The method of Claim 2 wherein one of the strands of each of die DNA fragments is labeled with biotin and attached to a streptavidin-coated bead. 13. The apparatus of Claim 10 wherein the double-stranded DNA retaining means is an externally-applied magnetic field 14. The method of Claim 2 wherein one of the strands of each of the multiplicity of DNA fragments is labeled with ferritin. 15. The apparatus of Claim 1 wherein the thermomodulating chamber is optionally comprised of a first opening and a second opening, wherein each of the openings is connected with a pumping means for passing a buffer solution through the thermomodulating chamber. 16. The method of Claim 2 wherein the solution comprising the multiplicity of DNA fragments optional comprises an isostabilizing compound. 17. A metiiod of determining the size of a DNA fragment, the method comprising the steps of: (a) placing a solution comprising the DNA fragment in the thermomodulating chamber of the apparatus of Claim 1 at a temperature less than the thermal-denaturation temperature of the DNA fragment; (b) incrementally increasing the temperamre of the thermomodulating chamber to a temperature that is at least the thermal denaturation temperature of the DNA fragment; and (c) detecting the thermal denaturation of the DNA fragment. 18. The method of Claim 17 wherein one of the strands of the DNA fragment is detectably labeled. 19. The method of Claim 18 wherein the detectable label is a fluorescent label. 20. The method of Claim 17 wherein one of the strands of the DNA fragment is labeled witii a tethering molecule. 21. The method of Claim 20 wherein the tethering molecule is biotin or ferritin. 22. The method of Claim 17 wherein the solution comprising the multiplicity of DNA fragments optional comprises an isostabilizing compound. 23. The method of Claim 17 wherein the multiplicity of DNA fragments comprises a standardized set of detectably-labeled fragments of DNA of known size. 24. A method for detecting a DNA fragment from a multiplicity of DNA fragments, the method comprising the steps of: (a) labeling one strand of each of die multiplicity of DNA fragments with a tethering molecule; (b) placing a solution of the multiplicity of labeled DNA fragments of subpart (a) in the thermomodulating chamber of the apparatus of Claim 8 wherein the DNA fragments of subpart (a) are retained by die retaining means; (c) raising the temperature of the thermomodulating chamber to a temperature sufficient to thermally denature the multiplicity of DNA fragments; (d) hybridizing the multiplicity of DNA fragments in a hybridization solution comprising a probe that is an oligonucleotide that specifically hybridizes to die DNA fragment among the multiplicity of DNA fragments, at a temperature sufficient to allow said hybridization to occur; (e) washing the excess unhybridized probe from the thermomodulating chamber; (f) incrementally increasing the temperature of the thermomodulating chamber to a temperature that is at least the thermal denaturation temperature of the hybridized oligonucleotide probe to denature die probe from the DNA fragment; and (g) detecting die thermal denaturation of the oligonucleotide probe from the DNA fragment. 25. The method of Claim 24 wherein one of the strands of die DNA fragment is detectably labeled. 26. The method of Claim 25 wherein the detectable label is a fluorescent label. 27. The method of Claim 24 wherein the solution comprising the multiplicity of DNA fragments optional comprises an isostabilizing compound. 28. A method of determining a nucleotide sequence in a DNA fragment, comprising the steps of: (a) labeling one strand of die DNA fragment with a tethering molecule; (b) placing a solution of the labeled DNA fragment of subpart (a) in the thermomodulating chamber of the apparatus of Claim 8 wherein the DNA fragment of subpart (a) is retained by the retaining means; (c) raising the temperature of the thermomodulating chamber to a temperature sufficient to thermally denature the DNA fragment; (d) hybridizing the DNA fragment in a hybridization solution comprising an oligonucleotide probe that specifically hybridizes to die DNA fragment at a site in the nucleotide sequence of the DNA fragment, at a temperature sufficient to allow said hybridization to occur; (e) performing a dideoxy nucleotide sequencing reaction on the DNA fragment to create a nested set of extended oligonucleotides hybridized to d e DNA fragment; (0 incrementally increasing the temperature of the thermomodulating chamber to a temperature that is at least the thermal denaturation temperature of each of the extended oligonucleotides hybridized to d e DNA fragment to denature each of the extended oligonucleotides from the DNA fragment; and (g) detecting the thermal denaturation of each of the extended oligonucleotides from the DNA fragment. 29. The method of Claim 28 wherein the dideoxy nucleotide sequencing reaction is performed using dideoxynucleotides diat are each detectably labeled witii a different fluorescent label, and d e detecting means of the apparatus is a fluorescence detector. 30. The method of Claim 28 wherein the solution comprising the multiplicity of extended oligonucleotides optional comprises an isostabilizing compound.

Inventors: MIAN ALEC, MIAN, ALEC
Applicants: GAMERA BIOSCIENCE CORP, MIAN ALEC, GAMERA BIOSCIENCE CORPORATION, MIAN, ALEC
Application year: 1995
Main classification: C12Q1
IPC codes: B01L7, C12M1, C12Q1, G01N33